{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T16:13:14Z","timestamp":1782490394631,"version":"3.54.5"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T00:00:00Z","timestamp":1664236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T00:00:00Z","timestamp":1664236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH126548"],"award-info":[{"award-number":["MH126548"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH122379"],"award-info":[{"award-number":["MH122379"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH123748"],"award-info":[{"award-number":["MH123748"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH122379"],"award-info":[{"award-number":["MH122379"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["HD103525"],"award-info":[{"award-number":["HD103525"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Neurosteroids that positively modulate GABA<jats:sub>A<\/jats:sub> receptors are among a growing list of rapidly acting antidepressants, including ketamine and psychedelics. To develop increasingly specific treatments with fewer side effects, we explored the possibility of EEG signatures in mice, which could serve as a cross-species screening tool. There are few studies of the impact of non-sedative doses of rapid antidepressants on EEG in either rodents or humans. Here we hypothesize that EEG features may separate a rapid antidepressant neurosteroid, allopregnanolone, from other GABA<jats:sub>A<\/jats:sub> positive modulators, pentobarbital and diazepam. Further, we compared the actions GABA modulators with those of ketamine, an NMDA antagonist and prototype rapid antidepressant. We examined EEG spectra during active exploration at two cortical locations and examined cross-regional and cross-frequency interactions. We found that at comparable doses, the effects of allopregnanolone, despite purported selectivity for certain GABA<jats:sub>A<\/jats:sub>R subtypes, was indistinguishable from pentobarbital during active waking exploration. The actions of diazepam had recognizable common features with allopregnanolone and pentobarbital but was also distinct, consistent with subunit selectivity of benzodiazepines. Finally, ketamine exhibited no distinguishing overlap with allopregnanolone in the parameters examined. Our results suggest that rapid antidepressants with different molecular substrates may remain separated at the level of large-scale ensemble activity, but the studies leave open the possibility of commonalities in more discrete circuits and\/or in the context of a dysfunctional brain.<\/jats:p>","DOI":"10.1038\/s41386-022-01450-x","type":"journal-article","created":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T18:03:58Z","timestamp":1664301838000},"page":"371-379","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Non-sedative cortical EEG signatures of allopregnanolone and functional comparators"],"prefix":"10.1038","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9427-638X","authenticated-orcid":false,"given":"Peter M.","family":"Lambert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Benz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas R.","family":"Rensing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles F.","family":"Zorumski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0868-0664","authenticated-orcid":false,"given":"Steven","family":"Mennerick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,27]]},"reference":[{"key":"1450_CR1","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1056\/NEJMoa1815981","volume":"381","author":"H Gunduz-Bruce","year":"2019","unstructured":"Gunduz-Bruce H, Silber C, Kaul I, Rothschild AJ, Riesenberg R, Sankoh AJ, et al. Trial of SAGE-217 in Patients with Major Depressive Disorder. N Engl J Med. 2019;381:903\u201311.","journal-title":"N Engl J Med"},{"key":"1450_CR2","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.2147\/DDDT.S240856","volume":"15","author":"A Walkery","year":"2021","unstructured":"Walkery A, Leader LD, Cooke E, Vandenberg A. Review of Allopregnanolone Agonist Therapy for the Treatment of Depressive Disorders. Drug Des Devel Ther. 2021;15:3017\u201326.","journal-title":"Drug Des Devel Ther"},{"key":"1450_CR3","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","volume":"47","author":"RM Berman","year":"2000","unstructured":"Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry. 2000;47:351\u20134.","journal-title":"Biol Psychiatry"},{"key":"1450_CR4","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","volume":"63","author":"CA Zarate","year":"2006","unstructured":"Zarate CA, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry. 2006;63:856\u201364.","journal-title":"Arch Gen Psychiatry"},{"key":"1450_CR5","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","volume":"384","author":"R Carhart-Harris","year":"2021","unstructured":"Carhart-Harris R, Giribaldi B, Watts R, Baker-Jones M, Murphy-Beiner A, Murphy R, et al. Trial of psilocybin versus escitalopram for depression. N Engl J Med. 2021;384:1402\u201311.","journal-title":"N Engl J Med"},{"key":"1450_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1093\/ijnp\/pyaa087","volume":"24","author":"B Kadriu","year":"2021","unstructured":"Kadriu B, Greenwald M, Henter ID, Gilbert JR, Kraus C, Park LT, et al. Ketamine and serotonergic psychedelics: Common mechanisms underlying the effects of rapid-acting antidepressants. Int J Neuropsychopharmacol. 2021;24:8\u201321.","journal-title":"Int J Neuropsychopharmacol"},{"key":"1450_CR7","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1126\/science.2422758","volume":"232","author":"MD Majewska","year":"1986","unstructured":"Majewska MD, Harrison NL, Schwartz RD, Barker JL, Paul SM. Steroid hormone metabolites are barbiturate-like modulators of the GABA Receptor. Science 1986;232:1004\u20137.","journal-title":"Science"},{"key":"1450_CR8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1124\/jpet.300.1.2","volume":"300","author":"H M\u00f6hler","year":"2002","unstructured":"M\u00f6hler H, Fritschy JM, Rudolph U. A new benzodiazepine pharmacology. J Pharm Exp Ther. 2002;300:2\u20138.","journal-title":"J Pharm Exp Ther"},{"key":"1450_CR9","first-page":"204","volume":"4","author":"X Hu","year":"2019","unstructured":"Hu X, Rocco BR, Fee C, Sibille E. Cell type-specific gene expression of Alpha 5 subunit-containing gamma-aminobutyric acid subtype a receptors in human and mouse frontal cortex. Mol Neuropsychiatry. 2019;4:204\u201315.","journal-title":"Mol Neuropsychiatry"},{"key":"1450_CR10","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1152\/jn.01122.2005","volume":"95","author":"J Glykys","year":"2006","unstructured":"Glykys J, Mody I. Hippocampal network hyperactivity after selective reduction of tonic inhibition in GABA A receptor alpha5 subunit-deficient mice. J Neurophysiol. 2006;95:2796\u2013807.","journal-title":"J Neurophysiol"},{"key":"1450_CR11","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1523\/JNEUROSCI.22-05-01541.2002","volume":"22","author":"KM Wohlfarth","year":"2002","unstructured":"Wohlfarth KM, Bianchi MT, Macdonald RL. Enhanced neurosteroid potentiation of ternary GABAA receptors containing the \u03b4 Subunit. J Neurosci. 2002;22:1541\u20139.","journal-title":"J Neurosci"},{"key":"1450_CR12","doi-asserted-by":"publisher","first-page":"14439","DOI":"10.1073\/pnas.2435457100","volume":"100","author":"BM Stell","year":"2003","unstructured":"Stell BM, Brickley SG, Tang CY, Farrant M, Mody I. Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by \u03b4 subunit-containing GABAA receptors. Proc Natl Acad Sci USA 2003;100:14439\u201344.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1450_CR13","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/nrn1703","volume":"6","author":"D Belelli","year":"2005","unstructured":"Belelli D, Lambert JJ. Neurosteroids: Endogenous regulators of the GABAA receptor. Nat Rev Neurosci. 2005;6:565\u201375. 2005 67","journal-title":"Nat Rev Neurosci"},{"key":"1450_CR14","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/S0165-0173(98)00052-6","volume":"29","author":"AK Mehta","year":"1999","unstructured":"Mehta AK, Ticku MK. An update on GABAA receptors. Brain Res Brain Res Rev. 1999;29:196\u2013217.","journal-title":"Brain Res Brain Res Rev"},{"key":"1450_CR15","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/0896-6273(90)90224-4","volume":"5","author":"E Sigel","year":"1990","unstructured":"Sigel E, Baur R, Trube G, M\u00f6hler H, Malherbe P. The effect of subunit composition of rat brain GABAA receptors on channel function. Neuron 1990;5:703\u201311.","journal-title":"Neuron"},{"key":"1450_CR16","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1124\/mol.104.002543","volume":"66","author":"HJ Feng","year":"2004","unstructured":"Feng HJ, Bianchi MT, Macdonald RL. Pentobarbital differentially modulates alpha1beta3delta and alpha1beta3gamma2L GABAA receptor currents. Mol Pharm. 2004;66:988\u20131003.","journal-title":"Mol Pharm"},{"key":"1450_CR17","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1124\/mol.56.1.110","volume":"56","author":"C Sur","year":"1999","unstructured":"Sur C, Farrar SJ, Kerby J, Whiting PJ, Atack JR, McKernan RM. Preferential coassembly of alpha4 and delta subunits of the gamma-aminobutyric acidA receptor in rat thalamus. Mol Pharm. 1999;56:110\u20135.","journal-title":"Mol Pharm"},{"key":"1450_CR18","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1523\/JNEUROSCI.18-05-01693.1998","volume":"18","author":"Z Nusser","year":"1998","unstructured":"Nusser Z, Sieghart W, Somogyi P. Segregation of different GABAA receptors to synaptic and extrasynaptic membranes of cerebellar granule cells. J Neurosci. 1998;18:1693\u2013703.","journal-title":"J Neurosci"},{"key":"1450_CR19","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/sj.bjp.0707665","volume":"153","author":"N Zheleznova","year":"2008","unstructured":"Zheleznova N, Sedelnikova A, Weiss DS. alpha1beta2delta, a silent GABAA receptor: recruitment by tracazolate and neurosteroids. Br J Pharm. 2008;153:1062\u201371.","journal-title":"Br J Pharm"},{"key":"1450_CR20","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/nn1813","volume":"10","author":"J Glykys","year":"2007","unstructured":"Glykys J, Peng Z, Chandra D, Homanics GE, Houser CR, Mody I. A new naturally occurring GABA(A) receptor subunit partnership with high sensitivity to ethanol. Nat Neurosci. 2007;10:40\u201348.","journal-title":"Nat Neurosci"},{"key":"1450_CR21","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1146\/annurev-neuro-062111-150444","volume":"35","author":"G Buzs\u00e1ki","year":"2012","unstructured":"Buzs\u00e1ki G, Wang X-J. Mechanisms of gamma oscillations. Annu Rev Neurosci. 2012;35:203\u201325.","journal-title":"Annu Rev Neurosci"},{"key":"1450_CR22","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1159\/000118148","volume":"12","author":"M Ansseau","year":"1984","unstructured":"Ansseau M, Doumont A, Cerfontaine JL, Mantanus H, Rousseau JC, Timsit-Berthier M. Self-reports of anxiety level and EEG changes after a single dose of benzodiazepines. Double-blind comparison of two forms of oxazepam. Neuropsychobiology 1984;12:255\u20139.","journal-title":"Neuropsychobiology"},{"key":"1450_CR23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.neuropharm.2012.09.014","volume":"65","author":"C Scheffz\u00fck","year":"2013","unstructured":"Scheffz\u00fck C, Kukushka VI, Vyssotski AL, Draguhn A, Tort ABL, Branka\u010dk J. Global slowing of network oscillations in mouse neocortex by diazepam. Neuropharmacology 2013;65:123\u201333.","journal-title":"Neuropharmacology"},{"key":"1450_CR24","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.biopsych.2021.07.017","volume":"91","author":"P Antonoudiou","year":"2022","unstructured":"Antonoudiou P, Colmers PLW, Walton NL, Weiss GL, Smith AC, Nguyen DP, et al. Allopregnanolone mediates affective switching through modulation of oscillatory states in the basolateral amygdala. Biol Psychiatry. 2022;91:283\u201393.","journal-title":"Biol Psychiatry"},{"key":"1450_CR25","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1126\/science.1190287","volume":"329","author":"N Li","year":"2010","unstructured":"Li N, Lee B, Liu RJ, Banasr M, Dwyer JM, Iwata M, et al. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 2010;329:959\u201364.","journal-title":"Science"},{"key":"1450_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep38808","volume":"6","author":"C Emnett","year":"2016","unstructured":"Emnett C, Li H, Jiang X, Benz A, Boggiano J, Conyers S, et al. A clickable analogue of ketamine retains NMDA receptor activity, psychoactivity, and accumulates in neurons. Sci Rep. 2016;6:1\u201317.","journal-title":"Sci Rep"},{"key":"1450_CR27","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0091-3057(00)00300-2","volume":"67","author":"RT Khisti","year":"2000","unstructured":"Khisti RT, Chopde CT, Jain SP. Antidepressant-like effect of the neurosteroid 3\u03b1-hydroxy-5\u03b1-pregnan-20-one in mice forced swim test. Pharm Biochem Behav. 2000;67:137\u201343.","journal-title":"Pharm Biochem Behav"},{"key":"1450_CR28","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.neuroimage.2010.08.064","volume":"54","author":"TA Whitten","year":"2011","unstructured":"Whitten TA, Hughes AM, Dickson CT, Caplan JB. A better oscillation detection method robustly extracts EEG rhythms across brain state changes: The human alpha rhythm as a test case. Neuroimage 2011;54:860\u201374.","journal-title":"Neuroimage"},{"key":"1450_CR29","unstructured":"Chronux. http:\/\/chronux.org\/. Accessed 21 June 2021."},{"key":"1450_CR30","doi-asserted-by":"crossref","unstructured":"Mitra P, Bokil H Observed Brain Dynamics. Oxford University Press; 2008.","DOI":"10.1093\/acprof:oso\/9780195178081.001.0001"},{"key":"1450_CR31","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1152\/jn.00106.2010","volume":"104","author":"ABL Tort","year":"2010","unstructured":"Tort ABL, Komorowski R, Eichenbaum H, Kopell N. Measuring phase-amplitude coupling between neuronal oscillations of different frequencies. J Neurophysiol. 2010;104:1195\u2013210.","journal-title":"J Neurophysiol"},{"key":"1450_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-52851-w","volume":"9","author":"M-Y Sun","year":"2019","unstructured":"Sun M-Y, Ziolkowski L, Lambert P, Shu H-J, Keiser M, Rensing N, et al. Mild chronic perturbation of inhibition severely alters hippocampal function. Sci Rep. 2019;9:16431.","journal-title":"Sci Rep"},{"key":"1450_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40810-015-0015-7","volume":"2","author":"SM Bowyer","year":"2016","unstructured":"Bowyer SM. Coherence a measure of the brain networks: Past and present. Neuropsychiatr Electrophysiol. 2016;2:1\u201312. 2016 21","journal-title":"Neuropsychiatr Electrophysiol"},{"key":"1450_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2017.198","volume":"7","author":"A Ahnaou","year":"2017","unstructured":"Ahnaou A, Huysmans H, Biermans R, Manyakov NV, Drinkenburg WHIM. Ketamine: Differential neurophysiological dynamics in functional networks in the rat brain. Transl Psychiatry. 2017;7:e1237.","journal-title":"Transl Psychiatry"},{"key":"1450_CR35","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.tics.2010.09.001","volume":"14","author":"RT Canolty","year":"2010","unstructured":"Canolty RT, Knight RT. The functional role of cross-frequency coupling. Trends Cogn Sci. 2010;14:506\u201315.","journal-title":"Trends Cogn Sci"},{"key":"1450_CR36","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1126\/science.1128115","volume":"313","author":"RT Canolty","year":"2006","unstructured":"Canolty RT, Edwards E, Dalal SS, Soltani M, Nagarajan SS, Kirsch HE, et al. High gamma power is phase-locked to theta oscillations in human neocortex. Science 2006;313:1626\u20138.","journal-title":"Science"},{"key":"1450_CR37","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1152\/jn.00539.2013","volume":"113","author":"EP Christian","year":"2015","unstructured":"Christian EP, Snyder DH, Song W, Gurley DA, Smolka J, Maier DL, et al. EEG-\u03b2\/\u03b3 spectral power elevation in rat: A translatable biomarker elicited by GABA(A\u03b12\/3)-positive allosteric modulators at nonsedating anxiolytic doses. J Neurophysiol. 2015;113:116\u201331.","journal-title":"J Neurophysiol"},{"key":"1450_CR38","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1124\/jpet.302.3.1158","volume":"302","author":"SAG Visser","year":"2002","unstructured":"Visser SAG, Smulders CJGM, Reijers BPR, Van Der Graaf PH, Peletier LA, Danhof M. Mechanism-based pharmacokinetic-pharmacodynamic modeling of concentration-dependent hysteresis and biphasic electroencephalogram effects of alphaxalone in rats. J Pharm Exp Ther. 2002;302:1158\u201367.","journal-title":"J Pharm Exp Ther"},{"key":"1450_CR39","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1124\/jpet.102.039610","volume":"303","author":"SAG Visser","year":"2002","unstructured":"Visser SAG, Gladdines WWFT, Graaf PH, van der, Peletier LA, Danhof M. Neuroactive steroids differ in potency but not in intrinsic efficacy at the GABAA receptor in vivo. J Pharm Exp Ther. 2002;303:616\u201326.","journal-title":"J Pharm Exp Ther"},{"key":"1450_CR40","doi-asserted-by":"publisher","first-page":"108333","DOI":"10.1016\/j.neuropharm.2020.108333","volume":"181","author":"AL Althaus","year":"2020","unstructured":"Althaus AL, Ackley MA, Belfort GM, Gee SM, Dai J, Nguyen DP, et al. Preclinical characterization of zuranolone (SAGE-217), a selective neuroactive steroid GABAA receptor positive allosteric modulator. Neuropharmacology 2020;181:108333.","journal-title":"Neuropharmacology"},{"key":"1450_CR41","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.bja.2020.07.022","volume":"126","author":"T Timic Stamenic","year":"2021","unstructured":"Timic Stamenic T, Feseha S, Manzella FM, Wallace D, Wilkey D, Corrigan T, et al. The T-type calcium channel isoform Ca v 3.1 is a target for the hypnotic effect of the anaesthetic neurosteroid (3\u03b2,5\u03b2,17\u03b2)-3-hydroxyandrostane-17-carbonitrile. Br J Anaesth. 2021;126:245\u201355.","journal-title":"Br J Anaesth"},{"key":"1450_CR42","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.bja.2021.03.029","volume":"127","author":"SM Joksimovic","year":"2021","unstructured":"Joksimovic SM, Sampath D, Krishnan K, Covey DF, Jevtovic-Todorovic V, Raol YH, et al. Differential effects of the novel neurosteroid hypnotic (3\u03b2,5\u03b2,17\u03b2)-3-hydroxyandrostane-17-carbonitrile on electroencephalogram activity in male and female rats. Br J Anaesth. 2021;127:435\u201346.","journal-title":"Br J Anaesth"},{"key":"1450_CR43","doi-asserted-by":"crossref","unstructured":"Kohtala S, Theilmann W, Rosenholm M, M\u00fcller HK, Kiuru P, Wegener G, et al. Ketamine-induced regulation of TrkB-GSK3\u03b2 signaling is accompanied by slow EEG oscillations and sedation but is independent of hydroxynorketamine metabolites. Neuropharmacology. 2019;157:107684.","DOI":"10.1016\/j.neuropharm.2019.107684"},{"key":"1450_CR44","doi-asserted-by":"publisher","first-page":"12905","DOI":"10.1073\/pnas.96.22.12905","volume":"96","author":"RM Mihalek","year":"1999","unstructured":"Mihalek RM, Banerjee PK, Korpi ER, Quinlan JJ, Firestone LL, Mi ZP, et al. Attenuated sensitivity to neuroactive steroids in g-aminobutyrate type A receptor d subunit knockout mice. Proc Natl Acad Sci USA 1999;96:12905\u201310.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1450_CR45","doi-asserted-by":"publisher","first-page":"RC223","DOI":"10.1523\/JNEUROSCI.22-10-j0003.2002","volume":"22","author":"BM Stell","year":"2002","unstructured":"Stell BM, Mody I. Receptors with different affinities mediate phasic and tonic GABAA conductances in hippocampal neurons. J Neurosci. 2002;22:RC223.","journal-title":"J Neurosci"},{"key":"1450_CR46","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1124\/jpet.115.229302","volume":"357","author":"CM Carver","year":"2016","unstructured":"Carver CM, Reddy DS. Neurosteroid structure-activity relationships for functional activation of extrasynaptic \u03b4GABAA receptors. J Pharm Exp Ther. 2016;357:188\u2013204.","journal-title":"J Pharm Exp Ther"},{"key":"1450_CR47","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.neuron.2013.03.007","volume":"77","author":"JE Lisman","year":"2013","unstructured":"Lisman JE, Jensen O. The \u03b8-\u03b3 neural code. Neuron 2013;77:1002\u201316.","journal-title":"Neuron"},{"key":"1450_CR48","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1213\/00000539-196501000-00028","volume":"44","author":"AL BRANDT","year":"1965","unstructured":"BRANDT AL, OAKES FD. Preanesthesia medication: double-blind study of a new drug, diazepam. Anesth Analg. 1965;44:125\u20139.","journal-title":"Anesth Analg"},{"key":"1450_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/srep02348","volume":"3","author":"FV Caixeta","year":"2013","unstructured":"Caixeta FV, Corn\u00e9lio AM, Scheffer-Teixeira R, Ribeiro S, Tort ABL. Ketamine alters oscillatory coupling in the hippocampus. Sci Rep. 2013;3:2348.","journal-title":"Sci Rep"},{"key":"1450_CR50","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1038\/mp.2015.176","volume":"21","author":"FR Carreno","year":"2016","unstructured":"Carreno FR, Donegan JJ, Boley AM, Shah A, DeGuzman M, Frazer A, et al. Activation of a ventral hippocampus-medial prefrontal cortex pathway is both necessary and sufficient for an antidepressant response to ketamine. Mol Psychiatry. 2016;21:1298\u2013308.","journal-title":"Mol Psychiatry"},{"key":"1450_CR51","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nrn3381","volume":"14","author":"SJ Russo","year":"2013","unstructured":"Russo SJ, Nestler EJ. The brain reward circuitry in mood disorders. Nat Rev Neurosci. 2013;14:609\u201325.","journal-title":"Nat Rev Neurosci"},{"key":"1450_CR52","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1038\/s41380-020-0686-8","volume":"26","author":"M Pignatelli","year":"2021","unstructured":"Pignatelli M, Tejeda HA, Barker DJ, Bontempi L, Wu J, Lopez A, et al. Cooperative synaptic and intrinsic plasticity in a disynaptic limbic circuit drive stress-induced anhedonia and passive coping in mice. Mol Psychiatry. 2021;26:1860\u201379.","journal-title":"Mol Psychiatry"},{"key":"1450_CR53","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1176\/appi.ajp.2018.17121358","volume":"176","author":"AS Widge","year":"2019","unstructured":"Widge AS, Bilge MT, Montana R, Chang W, Rodriguez CI, Deckersbach T, et al. Electroencephalographic biomarkers for treatment response prediction in major depressive illness: A meta-analysis. Am J Psychiatry. 2019;176:44\u201356.","journal-title":"Am J Psychiatry"},{"key":"1450_CR54","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.neuropharm.2005.04.026","volume":"49","author":"H Shen","year":"2005","unstructured":"Shen H, Qi HG, Yuan M, Smith SS. Short-term steroid treatment increases delta GABAA receptor subunit expression in rat CA1 hippocampus: pharmacological and behavioral effects. Neuropharmacology 2005;49:573\u201386.","journal-title":"Neuropharmacology"},{"key":"1450_CR55","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1523\/JNEUROSCI.4945-06.2007","volume":"27","author":"J Maguire","year":"2007","unstructured":"Maguire J, Mody I. Neurosteroid synthesis-mediated regulation of GABA(A) receptors: relevance to the ovarian cycle and stress. J Neurosci. 2007;27:2155\u201362.","journal-title":"J Neurosci"},{"key":"1450_CR56","doi-asserted-by":"publisher","first-page":"7132","DOI":"10.1073\/pnas.1403285111","volume":"111","author":"AM Abramian","year":"2014","unstructured":"Abramian AM, Comenencia-Ortiz E, Modgil A, Vien TN, Nakamura Y, Moore YE, et al. Neurosteroids promote phosphorylation and membrane insertion of extrasynaptic GABAA receptors. Proc Natl Acad Sci USA 2014;111:7132\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1450_CR57","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.neuropharm.2016.10.010","volume":"113","author":"A Modgil","year":"2017","unstructured":"Modgil A, Parakala ML, Ackley MA, Doherty JJ, Moss SJ, Davies PA. Endogenous and synthetic neuroactive steroids evoke sustained increases in the efficacy of GABAergic inhibition via a protein kinase C-dependent mechanism. Neuropharmacology 2017;113:314\u201322.","journal-title":"Neuropharmacology"},{"key":"1450_CR58","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.conb.2014.12.004","volume":"30C","author":"LM Monteggia","year":"2015","unstructured":"Monteggia LM, Zarate C Jr. Antidepressant actions of ketamine: From molecular mechanisms to clinical practice. Curr Opin Neurobiol. 2015;30C:139\u201343.","journal-title":"Curr Opin Neurobiol"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41386-022-01450-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-022-01450-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-022-01450-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T12:15:00Z","timestamp":1671020100000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-022-01450-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,27]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["1450"],"URL":"https:\/\/doi.org\/10.1038\/s41386-022-01450-x","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,27]]},"assertion":[{"value":"15 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal procedures were performed according to NIH guidelines and approved by the Washington University Institutional Animal Care and Use Committee, protocol 19-1036. Pain and suffering were alleviated with appropriate anesthesia and analgesia during surgical procedures. Animals were obtained from the Jackson Laboratory and were reared under the care of the Washington University School of Medicine Division of Comparative Medicine. Animals had <i>ad libitum<\/i> access to food and water throughout. Mice were euthanized at the end of studies according to NIH guidelines for minimizing pain. Other aspects of animal studies are described in the sections below.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}